SEC Form 4 · accession 0001209191-15-035526
ENTELLUS MEDICAL INC · ENTL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joshua J Baltzell
Director
Period of report
Apr 21, 2015
Accepted (ET)
Apr 22, 2015 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374128
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 21, 2015 | M | 1,250 | $11.36 | A | 1,250 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $11.36 | Apr 21, 2015 | M | 1,250 | D | — | Dec 16, 2024 | Common Stock | 1,250 | 13,750 | D |
Explanation of responses
- F1The option vests in quarterly installments over 36 months commencing on December 1, 2014 and on each quarterly anniversary thereafter, subject to continued service with the Issuer through each applicable vesting date.